The Ghrelin axis-does it have an appetite for cancer progression?

Endocrine Reviews

Volumn 33, Issue 6, 2012, Pages 849-891

  Chopin, Lisa K ^a   Seim, Inge ^a   Walpole, Carina M ^a   Herington, Adrian C ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GHRELIN RECEPTOR;

ANGIOGENESIS; APOPTOSIS; BODY MASS; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; GENE; GHRELIN RECEPTOR GENE; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CACHEXIA; CELL LINE, TUMOR; DISEASE PROGRESSION; GHRELIN; HUMANS; NEOPLASMS; RECEPTORS, GHRELIN;

EID: 84870995025     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2011-1007     Document Type: Review

References (397)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. 1999 Ghrelin is a growth hormone releasing acylated peptide from stomach. Nature 402:656-660
2. Bowers CY, Momany F, Reynolds GA, Chang D, Hong A, Chang K. 1980 Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology 106:663-667
3. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith R.G., Vander Ploeg LH. 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977
4. Smith RG. 2005 Development of growth hormone secretagogues. Endocr Rev 26:346-360
5. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR. 2001 Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
6. Tschöp M, Smiley DL, Heiman ML. 2000 Ghrelin induces adiposity in rodents. Nature 407:908-913
7. Tschöp M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, Landgraf R, Folwaczny C. 2001 Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 24:RC19-RC21
8. Granata R, Isgaard J, Alloatti G, Ghigo E. 2011 Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone. Exp Biol Med (Maywood) 236:505-514
9. Dixit VD, Taub DD. 2005 Ghrelin and immunity: a young player in an old field. Exp Gerontol 40:900-910
10. Granata R, Baragli A, Settanni F, Scarlatti F, Ghigo E. 2010 Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J Mol Endocrinol 45:107-118
11. Delhanty PJ, van der Lely AJ. 2011 Ghrelin and glucose homeostasis. Peptides 32:2309-2318
12. Hassouna R, Zizzari P, TolleV. 2010 The ghrelin/obestatin balance in the physiological and pathological control of growth hormone secretion, body composition and food intake. J Neuroendocrinol 22:793-804
13. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ. 2005 Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310:996-999
14. Zizzari P, Longchamps R, Epelbaum J, Bluet-Pajot MT. 2007 Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 148:1648-1653
15. Sibilia V, Bresciani E, Lattuada N, Rapetti D, Locatelli V, De Luca V, Dona' F, Netti C, Torsello A, Guidobono F. 2006 Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. J Endocrinol Invest 29:RC31-R34
16. SeoaneLM, Al-Massadi O, Pazos Y, Pagotto U, Casanueva FF. 2006 Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J Endocrinol Invest 29:RC13-RC15
17. Gourcerol G, Taché Y. 2007 Obestatin-a ghrelin-associated peptide that does not hold its promise to suppress food intake and motility. Neurogastroenterol Motil 19:161-165
18. Kobelt P, Wisser AS, Stengel A, Goebel M, Bannert N, Gourcerol G, Inhoff T, Noetzel S, Wiedenmann B, Klapp BF, Taché Y, Mönnikes H. 2008 Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents. Peptides 29:1018-1027
19. Gourcerol G, Coskun T, Craft LS, Mayer JP, Heiman ML, Wang L, Million M, St-Pierre DH, Taché Y. 2007 Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. Obesity (Silver Spring) 15:2643-2652
20. Tremblay F, Perreault M, Klaman LD, Tobin JF, Smith E, Gimeno RE. 2007 Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 148:501-506
21. Holst B, Egerod KL, Schild E, Vickers SP, Cheetham S, Gerlach LO, Storjohann L, Stidsen CE, Jones R, Beck-Sickinger AG, Schwartz TW. 2007 GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148: 13-20
22. Dong XY, He JM, Tang SQ, Li HY, Jiang QY, Zou XT. 2009 Is GPR39 the natural receptor of obestatin? Peptides 30:431-438
23. Lauwers E, Landuyt B, Arckens L, Schoofs L, LuytenW. 2006 Obestatin does not activate orphanGprotein-coupled receptor GPR39. Biochem Biophys Res Commun 351:21-25
24. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. 2008 Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132:387-396
25. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE, Hale JE. 2008 Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 105:6320-6325
26. ZhaoTJ, Liang G, Li RL, Xie X, SleemanMW, Murphy A.J., Valenzuela DM, Yancopoulos GD, Goldstein JL, Brown MS. 2010 Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci USA 107:7467-7472
27. Yi CX, Heppner KM, Kirchner H, Tong J, Bielohuby M, Gaylinn BD, Müller TD, Bartley E, Davis HW, Zhao Y, Joseph A, Kruthaupt T, Ottaway N, Kabra D, Habegger KM, Benoit SC, Bidlingmaier M, Thorner MO, Perez-Tilve D, Tschöp MH, Pfluger PT. 2012 The GOAT-ghrelin system is not essential for hypoglycemia prevention during prolonged calorie restriction. PLoS One 7:e32100
28. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M. 2000 Ghrelin, a novel growth hormone releasing acylated peptide is synthesised in a distinct endocrine cell type in gastrointestinal tracts of rats and humans. Endocrinology 141:4255-4261
29. Hosoda H, Kojima M, Matsuo H, Kangawa K. 2000 Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279:909-913
30. Baragli A, Ghe' C, Arnoletti E, Granata R, Ghigo E, Muccioli G. 2011 Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase _ and phosphodiesterase 3B. Biochim Biophys Acta 1811: 386-396
31. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, Abribat T, Van Der Lely AJ, Ghigo E. 2004 Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 89:3062-3065
32. Delhanty PJ, Sun Y, Visser JA, van Kerkwijk A, Huisman M, van Ijcken WF, Swagemakers S, Smith RG, Themmen AP, van der Lely AJ. 2010 Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice. PLoS One 5:e11749
33. Delhanty PJ, van der Eerden BC, van der Velde M, Gauna C, PolsHA, Jahr H, Chiba H, van der Lely AJ, van Leeuwen JP. 2006 Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a. J Endocrinol 188:37-47
34. Cassoni P, Papotti M, Ghe' C, Catapano F, Sapino A, Graziani A, Deghenghi R, Reissmann T, Ghigo E, Muccioli G. 2001 Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 86:1738-1745
35. Cassoni P, Ghé C, Marrocco T, Tarabra E, Allia E, Catapano F, Deghenghi R, Ghigo E, Papotti M, Muccioli G. 2004 Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 150:173-184
36. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, PratM, Muccioli G, Ghigo E, GrazianiA. 2002 Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI3-kinase/AKT. J Cell Biol 159:1029-1037
37. Korbonits M, Jacobs RA, Aylwin SJ, Burrin JM, Dahia PL, Monson JP, Honegger J, Fahlbush R, Trainer PJ, Chew SL, Besser GM, Grossman AB. 1998 Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. J Clin Endocrinol Metab 83:3624-3630
38. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, LoweDG, KangawaK, GrossmanAB. 2001The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumours. J Clin Endocrinol Metab 86: 881-887
39. Korbonits M, Kojima M, Kangawa K, Grossman AB. 2001 Presence of ghrelin in normal and adenomatous human pituitary. Endocrine 14:101-104
40. Kim K, Arai K, Sanno N, Osamura RY, Teramoto A, Shibasaki T. 2001 Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas. Clin Endocrinol (Oxf) 54:759-768
41. Nanzer AM, Khalaf S, Mozid AM, Fowkes RC, Patel MV, Burrin JM, Grossman AB, KorbonitsM. 2004 Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. Eur J Endocrinol 151:233-240
42. Murata M, Okimura Y, Iida K, Matsumoto M, Sowa H, Kaji H, Kojima M, Kangawa K, Chihara K. 2002 Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem 277:5667-5674
43. Jeffery PL, Herington AC, Chopin LK. 2002 Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol 172:R7-R11
44. Gröschl M, Topf HG, Bohlender J, Zenk J, Klussmann S, Dötsch J, Rascher W, RauhM. 2005 Identification of ghrelin in human saliva: production by the salivary glands and potential role in proliferation of oral keratinocytes. Clin Chem 51:997-1006
45. Inoue Y, Nakahara K, Kangawa K, Murakami N. 2010 Transitional change in rat fetal cell proliferation in response to ghrelin and des-acyl ghrelin during the last stage of pregnancy. Biochem Biophys Res Commun 393:455-460
46. Nakahara K, Nakagawa M, Baba Y, Sato M, Toshinai K, Date Y, Nakazato M, Kojima M, Miyazato M, Kaiya H, Hosoda H, Kangawa K, MurakamiN. 2006 Maternal ghrelin plays an important role in rat fetal development during pregnancy. Endocrinology 147:1333-1342
47. Moon M, Kim S, Hwang L, Park S. 2009 Ghrelin regulates hippocampal neurogenesis in adult mice. Endocr J 56:525-531
48. Ammori JB, Zhang WZ, Li JY, Chai BX, MulhollandMW. 2008 Effects of ghrelin on neuronal survival in cells derived from dorsal motor nucleus of the vagus. Surgery 144:159-167
49. Zhang W, Hu Y, Lin TR, Fan Y, Mulholland MW. 2005 Stimulation of neurogenesis in rat nucleus of the solitary tract by ghrelin. Peptides 26:2280-2288
50. Zhang W, Lin TR, Hu Y, Fan Y, Zhao L, Stuenkel EL, Mulholland MW. 2004 Ghrelin stimulates neurogenesis in the dorsal motor nucleus of the vagus. J Physiol 559:729-737
51. Sato M, Nakahara K, Goto S, Kaiya H, Miyazato M, Date Y, Nakazato M, Kangawa K, Murakami N. 2006 Effects of ghrelin and des-acyl ghrelin on neurogenesis of the rat fetal spinal cord. Biochem Biophys Res Commun 350:598-603
52. Wang DH, Hu YS, Du JJ, Hu YY, Zhong WD, Qin WJ. 2009 Ghrelin stimulates proliferation of human osteoblastic TE85 cells viaNO/cGMPsignaling pathway. Endocrine 35:112-117
53. Fukushima N, Hanada R, Teranishi H, Fukue Y, Tachibana T, Ishikawa H, Takeda S, Takeuchi Y, Fukumoto S, Kangawa K, Nagata K, Kojima M. 2005 Ghrelin directly regulates bone formation. J Bone Miner Res 20:790-798
54. Kim MS, Yoon CY, Jang PG, Park YJ, Shin CS, Park HS, Ryu JW, Pak YK, Park JY, Lee KU, Kim SY, Lee HK, Kim YB, Park KS. 2004 The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. MolEndocrinol 18:2291-2301
55. Zwirska-Korczala K, Adamczyk-Sowa M, Sowa P, Pilc K, Suchanek R, Pierzchala K, Namyslowski G, Misiolek M, Sodowski K, Kato I, Kuwahara A, Zabielski R. 2007 Role of leptin, ghrelin, angiotensin II and orexins in 3T3 L1 preadipocyte cells proliferation and oxidative metabolism. J Physiol Pharmacol 58(Suppl 1):53-64
56. Rossi F, Castelli A, Bianco MJ, Bertone C, Brama M, Santiemma V. 2008 Ghrelin induces proliferation in human aortic endothelial cells via ERK1/2 and PI3K/Akt activation. Peptides 29:2046-2051
57. Kim SW, Her SJ, Park SJ, Kim D, Park KS, Lee HK, Han BH, Kim MS, Shin CS, Kim SY. 2005 Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone 37:359-369
58. Zhang Y, Ying B, Shi L, Fan H, Yang D, Xu D, Wei Y, Hu X, Zhang Y, Zhang X, Wang T, Liu D, Dou L, Chen G, Jiang F, Wen F. 2007 Ghrelin inhibit cell apoptosis in pancreatic _ cell line HIT-T15 via mitogen-activated protein kinase/phosphoinositide 3-kinase pathways. Toxicology 237:194-202
59. Granata R, Settanni F, Biancone L, Trovato L, Nano R, Bertuzzi F, Destefanis S, Annunziata M, Martinetti M, Catapano F, Ghe' C, Isgaard J, Papotti M, Ghigo E, Muccioli G. 2007 Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic _-cells and human islets: involvement of 3_,5_-cyclic adenosine monophosphate/ protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology 148:512-529
60. Pettersson I, Muccioli G, Granata R, Deghenghi R, Ghigo E, Ohlsson C, Isgaard J. 2002 Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation. J Endocrinol 175:201-209
61. Rak-Mardyla A, Gregoraszczuk EL. 2010ERK1/2 and PI-3 kinase pathways as a potential mechanism of ghrelin action on cell proliferation and apoptosis in the porcine ovarian follicular cells. J Physiol Pharmacol 61:451-458
62. Sirotkin AV, Meszarosová M. 2010 Comparison of effects of leptin and ghrelin on porcine ovarian granulosa cells. Domest Anim Endocrinol 39:1-9
63. Andreis PG, Malendowicz LK, Trejter M, Neri G, Spinazzi R, Rossi GP, Nussdorfer GG. 2003 Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells. FEBS Lett 536:173-179
64. Mazzocchi G, Neri G, Rucinski M, Rebuffat P, Spinazzi R, Malendowicz LK, Nussdorfer GG. 2004 Ghrelin enhances the growth of cultured human adrenal zona glomerulosa cells by exerting MAPK-mediated proliferogenic and antiapoptotic effects. Peptides 25:1269-1277
65. Ceranowicz P, Warzecha Z, Dembinski A, Sendur R, Cieszkowski J, Ceranowicz D, Pawlik WW, Kuwahara A, Kato I, Konturek PC. 2009 Treatment with ghrelin accelerates the healing of acetic acid-induced gastric and duodenal ulcers in rats. J Physiol Pharmacol 60:87-98
66. de Segura IA, Vallejo-Cremades MT, Lomas J, Sánchez MF, Caballero MI, Largo C, De Miguel E. 2010 Exogenous ghrelin regulates proliferation and apoptosis in the hypotrophic gut mucosa of the rat. Exp Biol Med (Maywood) 235:463-469
67. Zhan M, Yuan F, Liu H, Chen H, Qiu X, Fang W. 2008 Inhibition of proliferation and apoptosis of vascular smooth muscle cells by ghrelin. Acta Biochim Biophys Sin (Shanghai) 40:769-776
68. Barreiro ML, Gaytan F, Castellano JM, Suominen JS, Roa J, Gaytan M, Aguilar E, Dieguez C, Toppari J, Tena-Sempere M. 2004 Ghrelin inhibits the proliferative activity of immature Leydig cells in vivo and regulates stem cell factor messenger ribonucleic acid expression in rat testis. Endocrinology 145:4825-4834
69. Delhanty PJ, van Koetsveld PM, Gauna C, van de Zande B, Vitale G, Hofland LJ, van der Lely AJ. 2007 Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway. Am J Physiol Endocrinol Metab 293:E302-E309
70. Jeffery PL, Murray RE, Yeh AH, McNamara JF, Duncan RP, Francis GD, Herington AC, Chopin LK. 2005 Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr Relat Cancer 12:839-850
71. Gahete MD, Córdoba-Chacón J, Hergueta-Redondo M, Martínez-Fuentes AJ, Kineman RD, Moreno-Bueno G, Luque RM, Castaño JP. 2011 A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance. PLoS One 6:e23302
72. Rak-Mardyła A, Gregoraszczuk E. 2010 Effect of ghrelin on proliferation, apoptosis and secretion of progesterone and hCG in the placental JEG-3 cell line. Reprod Biol 10: 159-165
73. Waseem T, Javaid-Ur-Rehman, Ahmad F, Azam M, Qureshi MA. 2008 Role of ghrelin axis in colorectal cancer: a novel association. Peptides 29:1369-1376
74. Fung JN, Seim I, Wang D, Obermair A, Chopin LK, Chen C. 2010 Expression and in vitro functions of the ghrelin axis in endometrial cancer. Horm Cancer 1:245-255
75. DeVriese C, Grégoire F, DeNeef P, Robberecht P, Delporte C. 2005 Ghrelin is produced by the human erythroleukemic HELcell line and involved in an autocrine pathway leading to cell proliferation. Endocrinology 146:1514-1522
76. DeVriese C, DelporteC. 2007 Autocrine proliferative effect of ghrelin on leukemic HL-60 and THP-1 cells. J Endocrinol 192:199-205
77. Duxbury MS, Waseem T, Ito H, Robinson MK, Zinner MJ, Ashley SW, Whang EE. 2003 Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem Biophys Res Commun 309:464-468
78. Maccarinelli G, Sibilia V, Torsello A, Raimondo F, Pitto M, Giustina A, Netti C, Cocchi D. 2005 Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 184:249-256
79. Díaz-Lezama N, Hernández-Elvira M, Sandoval A, Monroy A, Felix R, Monjaraz E. 2010 Ghrelin inhibits proliferation and increases T-type Ca2_ channel expression in PC-3 human prostate carcinoma cells. Biochem Biophys Res Commun 403:24-29
80. Cassoni P, Allia E, Marrocco T, Ghe' C, Ghigo E, Muccioli G, Papotti M. 2006 Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line. J Endocrinol Invest 29:781-790
81. Volante M, Allia E, Fulcheri E, Cassoni P, Ghigo E, Muccioli G, Papotti M. 2003 Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. Am J Pathol 162:645-654
82. Zhang Q, Huang WD, Lv XY, Yang YM. 2011 Ghrelin protects H9c2 cells from hydrogen peroxide-induced apoptosis through NF-_B and mitochondria-mediated signaling. Eur J Pharmacol 654:142-149
83. He XT, Fan XM, Zha XL. 2011 Ghrelin inhibits 5-fluorouracil-induced apoptosis in colonic cancer cells. J Gastroenterol Hepatol 26:1169-1173
84. Yang M, Hu S, WuB, Miao Y, Pan H, Zhu S. 2007 Ghrelin inhibits apoptosis signal-regulating kinase 1 activity via upregulating heat-shock protein 70. Biochem Biophys Res Commun 359:373-378
85. Xiang Y, Li Q, Li M, Wang W, Cui C, Zhang J. 2011 Ghrelin inhibits AGEs-induced apoptosis in human endothelial cells involving ERK1/2 and PI3K/Akt pathways. Cell Biochem Funct 29:149-155
86. Zhao H, Liu G, Wang Q, Ding L, Cai H, Jiang H, Xin Z. 2007 Effect of ghrelin onhumanendothelial cells apoptosis induced by high glucose. Biochem Biophys Res Commun 362:677-681
87. Favaro E, Granata R, Miceli I, Baragli A, Settanni F, Cavallo Perin P, Ghigo E, Camussi G, Zanone MM. 2012 The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways. Diabetologia 55: 1058-1070
88. Park JM, Kakimoto T, Kuroki T, Shiraishi R, Fujise T, Iwakiri R, Fujimoto K. 2008 Suppression of intestinal mucosal apoptosis by ghrelin in fasting rats. Exp Biol Med (Maywood) 233:48-56
89. Chung H, Kim E, Lee DH, Seo S, Ju S, Lee D, Kim H, Park S. 2007 Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 148:148-159
90. Chung H, Seo S, Moon M, Park S. 2008 Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 _ and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelinagainstoxygen-glucosedeprivation-inducedapoptosisin primary rat cortical neuronal cells. J Endocrinol 198:511-521
91. Wang G, Wang W, Zhao J, Ni Y, Zhou X, Zhang W. 2011 Ghrelin prevents neuronal apoptosis and cognitive impairments in sepsis-associated encephalopathy. Neuroreport 22:959-964
92. Sirotkin AV, Meszarošová M, Grossmann R, Bene'o A, Valenzuela F. 2011 Effect of inhibitor and activator of ghrelin receptor (GHS-R1a) on porcine ovarian granulosa cell functions. Gen Comp Endocrinol 173:105-110
93. Granado M, Chowen JA, García-Cáceres C, Delgado-Rubín A, Barrios V, Castillero E, Argente J, Frago LM. 2009 Ghrelin treatment protects lactotrophs from apoptosis in the pituitary of diabetic rats. Mol Cell Endocrinol 309:67-75
94. Granata R, Settanni F, Gallo D, Trovato L, Biancone L, Cantaluppi V, Nano R, Annunziata M, Campiglia P, Arnoletti E, Ghe' C, VolanteM, PapottiM, Muccioli G, Ghigo E. 2008 Obestatin promotes survival of pancreatic β-cells and human islets and induces expression of genes involved in the regulation of _-cell mass and function. Diabetes 57: 967-979
95. Camiña JP, Campos JF, Caminos JE, Dieguez C, Casanueva FF. 2007 Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms. J Cell Physiol 211:1-9
96. Granata R, Volante M, Settanni F, Gauna C, Ghé C, Annunziata M, Deidda B, Gesmundo I, Abribat T, van der Lely AJ, Muccioli G, Ghigo E, Papotti M. 2010 Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats. J Mol Endocrinol 45:9-17
97. Pazos Y, Alvarez CJ, Camiña JP, Casanueva FF. 2007 Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-III by obestatin. Growth Factors 25:373-381
98. Volante M, Rosas R, Ceppi P, Rapa I, Cassoni P, Wiedenmann B, Settanni F, Granata R, Papotti M. 2009 Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth. J Pathol 218:458-466
99. Lago R, Gomez R, Dieguez C, Gomez-Reino JJ, Lago F, Gualillo O. 2007 Unlike ghrelin, obestatin does not exert any relevant activity in chondrocytes. Ann Rheum Dis 66: 1399-1400
100. Dossus L, McKay JD, Canzian F, Wilkening S, Rinaldi S, Biessy C, Olsen A, Tjønneland A, Jakobsen MU, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Fournier A, Linseisen J, Lukanova A, Boeing H, Fisher E, Trichopoulou A, Georgila C, Trichopoulos D, Palli D, Krogh V, Tumino R, Vineis P, Quirós JR, Sala N, Martínez-García C, Dorronsoro M, Chirlaque MD, Barricarte A, van Duijnhoven FJ, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Hallmans G, Lenner P, Bingham S, Khaw KT, Key TJ, Travis RC, Ferrari P, Jenab M, Riboli E, Kaaks R. 2008 Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC). Carcinogenesis 29:1360-1366
101. Skibola DR, Smith MT, Bracci PM, Hubbard AE, Agana L, Chi S, Holly EA. 2005 Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 14:1251-1256
102. Chung WK, Patki A, Matsuoka N, Boyer BB, Liu N, Musani SK, Goropashnaya AV, Tan PL, Katsanis N, Johnson SB, Gregersen PK, Allison DB, Leibel RL, TiwariHK. 2009 Analysis of 30 genes (355 SNPS) related to energy homeostasis for association with adiposity in European-American and Yup'ik Eskimo populations. Hum Hered 67:193-205
103. Campa D, Pardini B, Naccarati A, Vodickova L, Novotny J, Steinke V, Rahner N, Holinski-Feder E, Morak M, Schackert HK, Görgens H, Kötting J, Betz B, Kloor M, Engel C, Büttner R, Propping P, Försti A, Hemminki K, Barale R, Vodicka P, Canzian F. 2010 Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study. BMC Gastroenterol 10:112
104. DeBoer MD. 2008 Emergence of ghrelin as a treatment for cachexia syndromes. Nutrition 24:806-814
105. Wajnrajch MP, Ten IS, Gertner JM, Leibel RL. 2000 Genomic organization of the human GHRELIN gene. J Endocrine Genet 1:231-233
106. Seim I, Collet C, Herington AC, Chopin LK. 2007 Revised genomic structure of the human ghrelin gene and identification of novel exons, alternative splice variants and natural antisense transcripts. BMC Genomics 8:298
107. Kanamoto N, Akamizu T, Tagami T, Hataya Y, Moriyama K, Takaya K, Hosoda H, Kojima M, Kangawa K, Nakao K. 2004 Genomic structure and characterization of the 5_-flanking region of the human ghrelin gene. Endocrinology 145:4144-4153
108. Pemberton C, Wimalasena P, Yandle T, Soule S, Richards M. 2003 C-terminal pro-ghrelin peptides are present in the human circulation. Biochem Biophys Res Commun 310: 567-573
109. Takahashi T, Ida T, Sato T, Nakashima Y, Nakamura Y, Tsuji A, Kojima M. 2009 Production of n-octanoyl-modified ghrelin in cultured cells requires prohormone processing protease and ghrelin O-acyltransferase, as well as n-octanoic acid. J Biochem 146:675-682
110. Zhu X, Cao Y, Voogd K, Voodg K, Steiner DF. 2006Onthe processing of proghrelin to ghrelin. J Biol Chem 281: 38867-38870
111. Holmes E, Davies I, Lowe G, Ranganath LR. 2009 Circulating ghrelin exists in both lipoprotein bound and free forms. Ann Clin Biochem 46:514-516
112. Patterson M, Murphy KG, le Roux CW, Ghatei MA, Bloom SR. 2005 Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab 90: 2205-2211
113. Satou M, Nishi Y, Yoh J, Hattori Y, Sugimoto H. 2010 Identification and characterization of acyl-protein thioesterase 1/lysophospholipase I as a ghrelin deacylation/lysophospholipid hydrolyzing enzyme in fetal bovine serum and conditioned medium. Endocrinology 151:4765-4775
114. De Vriese C, Gregoire F, Lema-Kisoka R, Waelbroeck M, Robberecht P, Delporte C. 2004 Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 145:4997-5005
115. De Vriese C, Hacquebard M, Gregoire F, Carpentier Y, Delporte C. 2007 Ghrelin interacts with human plasma lipoproteins. Endocrinology 148:2355-2362
116. Satou M, Nakamura Y, Ando H, Sugimoto H. 2011 Understanding the functional significance of ghrelin processing and degradation. Peptides 32:2183-2190
117. Hosoda H, Kojima M, Mizushima T, Shimizu S, Kangawa K. 2003 Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem 278:64-70
118. Yoh J, Nishi Y, Hosoda H, Tajiri Y, Yamada K, Yanase T, Doi R, Yonemoto K, Kangawa K, Kojima M, Tanaka E, Kusukawa J. 2011 Plasma levels of n-decanoyl ghrelin, another acyl- and active-form of ghrelin, in human subjects and the effect of glucose- or meal-ingestion on its dynamics. Regul Pept 167:140-148
119. Hosoda H, Kojima M, Matsuo H, Kangawa K. 2000 Purification and characterization of rat des-Gln14-ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem 275:21995-22000
120. Bedendi I, Alloatti G, Marcantoni A, Malan D, Catapano F, Ghé C, Deghenghi R, Ghigo E, Muccioli G. 2003 Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. Eur J Pharmacol 476:87-95
121. Seim I, Herington AC, Chopin LK. 2009 New insights into the molecular complexity of the ghrelin gene locus. Cytokine Growth Factor Rev 20:297-304
122. Seim I, Carter SL, Herington AC, Chopin LK. 2008 Complex organisation and structure of the ghrelin antisense strand gene GHRLOS, a candidate non-codingRNAgene. BMC Mol Biol 9:95
123. Nakai N, Kaneko M, Nakao N, Fujikawa T, Nakashima K, Ogata M, Tanaka M. 2004 Identification of promoter region of ghrelin gene in human medullary thyroid carcinoma cell line. Life Sci 75:2193-2201
124. WeiW, WangG, Qi X, Englander EW, Greeley Jr GH. 2005 Characterization and regulation of the rat and human ghrelin promoters. Endocrinology 146:1611-1625
125. Kishimoto M, Okimura Y, Nakata H, Kudo T, Iguchi G, Takahashi Y, Kaji H, Chihara K. 2003 Cloning and characterization of the 5(_)-flanking region of the human ghrelin gene. Biochem Biophys Res Commun 305:186-192
126. Jeffery PL, Duncan RP, Yeh AH, Jaskolski RA, Hammond DS, Herington AC, Chopin LK. 2005 Expression of the ghrelin axis in the mouse: an exon 4-deleted mouse proghrelin variant encodes a novel C terminal peptide. Endocrinology 146:432-440
127. Yeh AH, Jeffery PL, Duncan RP, Herington AC, Chopin LK. 2005 Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin Cancer Res 11:8295-8303
128. Gahete MD, Córdoba-Chacón J, Salvatori R, Castaño JP, Kineman RD, Luque RM. 2010 Metabolic regulation of ghrelin O-acyl transferase (GOAT) expression in the mouse hypothalamus, pituitary, and stomach. Mol Cell Endocrinol 317:154-160
129. McKee KK, Palyha OC, Feighner SD, Hreniuk DL, Tan CP, Phillips MS, Smith RG, Vander Ploeg LH, Howard AD. 1997 Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol Endocrinol 11:415-423
130. Petersenn S. 2002 Structure and regulation of the growth hormone secretagogue receptor. Minerva Endocrinol 27: 243-256
131. Leung PK, Chow KB, Lau PN, Chu KM, Chan CB, Cheng CH, Wise H. 2007 The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor. Cell Signal 19:1011-1022
132. Chu KM, Chow KB, Leung PK, Lau PN, Chan CB, Cheng CH, Wise H. 2007 Over-expression of the truncated ghrelin receptor polypeptide attenuates the constitutive activation of phosphatidylinositol-specific phospholipase C by ghrelin receptors but has no effect on ghrelin-stimulated extracellular signal-regulated kinase 1/2 activity. Int J Biochem Cell Biol 39:752-764
133. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M. 2002 The tissue distribution of themRNAof ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988
134. Kojima M, Kangawa K. 2005 Ghrelin: structure and function. Physiol Rev 85:495-522
135. Camiña JP. 2006 Cell biology of the ghrelin receptor. J Neuroendocrinol 18:65-76
136. Soares JB, Leite-Moreira AF. 2008 Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides 29:1255-1270
137. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH, Howard AD. 1997 Distribution ofmRNAencoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 48:23-29
138. Hattori N, Saito T, Yagyu T, Jiang BH, Kitagawa K, Inagaki C. 2001 GH, GHreceptor, GHsecretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab 86:4284-4291
139. Thielemans L, Peeters PJ, Jonckheere H, Luyten W, de Hoogt R, Coulie B, Aerssens J. 2007 The hepatocarcinoma cell line HepG2 does not express a GHS-R1a-type ghrelin receptor. J Recept Signal Transduct Res 27:309-322
140. Filigheddu N, Gnocchi VF, Coscia M, Cappelli M, Porporato PE, Taulli R, Traini S, Baldanzi G, Chianale F, Cutrupi S, Arnoletti E, Ghe' C, Fubini A, Surico N, Sinigaglia F, Ponzetto C, Muccioli G, Crepaldi T, Graziani A. 2007 Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell 18: 986-994
141. Kleinz MJ, Maguire JJ, Skepper JN, Davenport AP. 2006 Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res 69:227-235
142. Gauna C, Delhanty PJ, Hofland LJ, Janssen JA, Broglio F, Ross RJ, Ghigo E, van der Lely AJ. 2005 Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 90:1055-1060
143. Gauna C, Delhanty PJ, van Aken MO, Janssen JA, Themmen AP, Hofland LJ, Culler M, Broglio F, Ghigo E, van der Lely AJ. 2006 Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. Mol Cell Endocrinol 251:103-111
144. Muccioli G, Pons N, Ghe' C, Catapano F, Granata R, Ghigo E. 2004 Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur J Pharmacol 498:27-35
145. ThompsonNM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC, Wells T. 2004 Ghrelin and des-octanolyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145:234-242
146. Toshinai K, Yamaguchi H, Sun Y, Smith RG, Yamanaka A, Sakurai T, Date Y, Mondal MS, Shimbara T, Kawagoe T, Murakami N, Miyazato M, Kangawa K, Nakazato M. 2006 Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147:2306-2314
147. Popovics P, Stewart AJ. 2011 GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions. Cell Mol Life Sci 68: 85-95
148. Moechars D, Depoortere I, Moreaux B, de Smet B, Goris I, Hoskens L, Daneels G, Kass S, Ver Donck L, Peeters T, Coulie B. 2006 Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse. Gastroenterology 131:1131-1141
149. De Smet B, Thijs T, Peeters TL, Depoortere I. 2007 Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil 19: 211-217
150. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR. 2000 The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141:4325-4328
151. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M. 2002 The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123:1120-1128
152. Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, Hosoda H, Kojima M, Kangawa K. 2000 Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 276:905-908
153. Fukuda H, Mizuta Y, Isomoto H, Takeshima F, Ohnita K, Ohba K, Omagari K, Taniyama K, Kohno S. 2004 Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats. Scand J Gastroenterol 39:1209-1214
154. Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S. 2001 Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun 280:904-907
155. Tong J, Mannea E, Aimé P, Pfluger PT, Yi CX, Castaneda TR, Davis HW, Ren X, Pixley S, Benoit S, Julliard K, Woods SC, Horvath TL, Sleeman M M., D'Alessio D, Obici S, Frank R, Tschöp MH. 2011 Ghrelin enhances olfactory sensitivity and exploratory sniffing in rodents and humans. J Neurosci 31:5841-5846
156. Shin YK, Martin B, Kim W, White CM, Ji S, Sun Y, Smith RG, Sévigny J, Tschöp MH, Maudsley S, Egan JM. 2010 Ghrelin is produced in taste cells and ghrelin receptor null mice show reduced taste responsivity to salty (NaCl) and sour (citric acid) tastants. PLoS One 5:e12729
157. Jerlhag E, Egecioglu E, Landgren S, Salomé N, Heilig M, Moechars D, Datta R, Perrissoud D, Dickson SL, Engel JA. 2009 Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci USA 106:11318-11323
158. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. 2001 Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707-709
159. Shimizu Y, Nagaya N, Isobe T, Imazu M, Okumura H, Hosoda H, Kojima M, Kangawa K, Kohno N. 2003 Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 9:774-778
160. Yi CX, Heppner K, Tschöp MH. 2011 Ghrelin in eating disorders. Mol Cell Endocrinol 340:29-34
161. Tan TM, Vanderpump M, Khoo B, Patterson M, Ghatei MA, Goldstone AP. 2004 Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome. J Clin Endocrinol Metab 89: 4162-4165
162. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS. 2002 Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 8:643-644
163. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ. 2002 Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623-1630
164. Kang K, Zmuda E, Sleeman MW. 2011 Physiological role of ghrelin as revealed by the ghrelin and GOAT knockout mice. Peptides 32:2236-2241
165. Sun Y, Ahmed S, Smith RG. 2003 Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23:7973-7981
166. Sun Y, Ahmed S., Smith R, Generation and characterisation of ghrelin knockout mice. Program of the 84th Annual Meeting of The Endocrine Society, San Francisco, CA, 2002, p 195 (Abstract P1-174)
167. Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, Liu R, Moncrieffe M, Thabet K, Cox HJ, Yancopoulos GD, Wiegand SJ, Sleeman MW. 2004 Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 101:8227-8232
168. Wortley KE, del Rincon JP, Murray JD, Garcia K, Iida K, Thorner MO, Sleeman MW. 2005 Absence of ghrelin protects against early-onset obesity. J Clin Invest 115:3573-3578
169. Dezaki K, Sone H, KoizumiM, NakataM, KakeiM, Nagai H, Hosoda H, Kangawa K, Yada T. 2006 Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 55:3486-3493
170. Sun Y, Wang P, Zheng H, Smith RG. 2004 Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 101:4679-4684
171. Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, Lee CE, Jones JE, Deysher AE, Waxman AR, White RD, Williams TD, Lachey JL, Seeley RJ, Lowell BB, Elmquist JK. 2005 Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 115: 3564-3572
172. Pfluger PT, Kirchner H, Günnel S, Schrott B, Perez-Tilve D, Fu S, Benoit SC, Horvath T, Joost HG, Wortley KE, Sleeman MW, Tschöp MH. 2008 Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. Am J Physiol Gastrointest Liver Physiol 294: G610-G618
173. Sun Y, Butte NF, Garcia JM, Smith RG. 2008 Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology 149:843-850
174. Sakata I, Yang J, Lee CE, Osborne-Lawrence S, Rovinsky SA, Elmquist JK, Zigman JM. 2009 Colocalization of ghrelin O-acyltransferase and ghrelin in gastric mucosal cells. Am J Physiol Endocrinol Metab 297:E134-E141
175. Kirchner H, Gutierrez JA, Solenberg PJ, Pfluger PT, Czyzyk TA, Willency JA, Schürmann A, Joost HG, Jandacek RJ, Hale JE, Heiman ML, Tschöp MH. 2009 GOAT links dietary lipids with the endocrine control of energy balance. Nat Med 15:741-745
176. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Fujimiya M, Katsuura G, Makino S, Fujino MA, Kasuga M. 2001 A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 74:143-147
177. Carlini VP, Monzón ME, Varas MM, Cragnolini AB, Schiöth HB, Scimonelli TN, de Barioglio SR. 2002 Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem Biophys Res Commun 299:739-743
178. Weikel JC, Wichniak A, IsingM, Brunner H, Friess E, Held K, Mathias S, Schmid DA, Uhr M, Steiger A. 2003 Ghrelin promotes slow-wave sleep in humans. Am J Physiol Endocrinol Metab 284:E407-E415
179. Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, Hayashi Y, Kangawa K. 2001 Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280: R1483-R1487
180. Nagaya N, Kangawa K. 2003 Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr Opin Pharmacol 3:146-151
181. Tesauro M, Schinzari F, Caramanti M, Lauro R, Cardillo C. 16 March 2010 Metabolic and cardiovascular effects of ghrelin. Int J Pept 10.1155/2010/864342
182. Zhang D, Wang W, Zhou D, Chen Y, Han L, Liu Y, Cao C, Zhao H, Liu G. 2010 Ghrelin inhibits apoptosis induced by palmitate in rat aortic endothelial cells. Med Sci Monit 16:BR396-BR403
183. Salehi A, Dornonville de la Cour C, Håkanson R, Lundquist I. 2004 Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice. Regul Pept 118:143-150
184. Sun Y, Asnicar M, Smith RG. 2007 Central and peripheral roles of ghrelin on glucose homeostasis. Neuroendocrinology 86:215-228
185. Dezaki K, Sone H, Yada T. 2008 Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther 118:239-249
186. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard Jr JW, Taub DD. 2004 Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114:57-66
187. Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL, McCormick ML, Sigmund CD, Tang C, Weintraub NL. 2004 Ghrelin inhibits proinflammatory responses and nuclear factor-_B activation in human endothelial cells. Circulation 109:2221-2226
188. Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shinfuku N, Ueta Y, Meguid MM, Kasuga M. 2005 Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 54:18-24
189. Chen CY, Chao Y, Chang FY, Chien EJ, Lee SD, Doong ML. 2005 Intracisternal des-acyl ghrelin inhibits food intake and non-nutrient gastric emptying in conscious rats. Int J Mol Med 16:695-699
190. Neary N.M., DruceMR, Small CJ, Bloom SR. 2006 Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut 55:135
191. Mayorov AV, Amara N, Chang JY, Moss JA, Hixon MS, Ruiz DI, Meijler MM, Zorrilla EP, Janda KD. 2008 Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice. Proc Natl Acad Sci USA 105:17487-17492
192. Ariyasu H, Takaya K, Iwakura H, Hosoda H, Akamizu T, Arai Y, Kangawa K, Nakao K. 2005 Transgenic mice overexpressing des-acyl ghrelin show small phenotype. Endocrinology 146:355-364
193. Liu J, Prudom CE, Nass R, Pezzoli SS, Oliveri M.C., Johnson ML, Veldhuis P, Gordon DA, Howard AD, Witcher DR, Geysen HM, Gaylinn BD, Thorner MO. 2008 Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J Clin Endocrinol Metab 93:1980-1987
194. Granata R, Settanni F, Trovato L, Destefanis S, Gallo D, Martinetti M, Ghigo E, Muccioli G. 2006 Unacylated as well as acylated ghrelin promotes cell survival and inhibit apoptosis in HIT-T15 pancreatic _-cells. J Endocrinol Invest 29:RC19-RC22
195. Bassil AK, Häglund Y, Brown J, Rudholm T, Hellström PM, Näslund E, Lee K, Sanger GJ. 2007 Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol 150:58-64
196. Chartrel N, Alvear-Perez R, Leprince J, Iturrioz X, Reaux-Le Goazigo A, Audinot V, Chomarat P, Coge F, Nosjean O, Rodriguez M., Galizzi JP, Boutin JA, Vaudry H, Llorens-Cortes C. 2007 Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake." Science 315:766;author reply 766
197. Mondal MS, Toshinai K, Ueno H, Koshinaka K, Nakazato M. 2008 Characterization of obestatin in rat and human stomach and plasma, and its lack of acute effect on feeding behavior in rodents. J Endocrinol 198:339-346
198. Nogueiras R, Pfluger P, Tovar S, Arnold M, Mitchell S, Morris A, Perez-Tilve D, Vázquez MJ, Wiedmer P, Castañeda TR, DiMarchi R, Tschöp M, Schurmann A, Joost HG, Williams LM, Langhans W, Diéguez C. 2007 Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 148:21-26
199. Unniappan S, Speck M, Kieffer TJ. 2008 Metabolic effects of chronic obestatin infusion in rats. Peptides 29:1354-1361
200. Van Dijck A, Van Dam D, Vergote V, De Spiegeleer B, Luyten W, Schoofs L, De Deyn PP. 2009 Central administration of obestatin fails to show inhibitory effects on food and water intake in mice. Regul Pept 156:77-82
201. Yamamoto D, Ikeshita N, Daito R, Herningtyas EH, Toda K, Takahashi K, Iida K, Takahashi Y, Kaji H, Chihara K, Okimura Y. 2007 Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats. Regul Pept 138: 141-144
202. Miegueu P, St Pierre D, Broglio F, Cianflone K. 2011 Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J Cell Biochem 112:704-714
203. Szentirmai E, Krueger JM. 2006 Obestatin alters sleep in rats. Neurosci Lett 404:222-226
204. Carlini VP, Schiöth HB, Debarioglio SR. 2007 Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun 352:907-912
205. Samson WK, Yosten GL, Chang JK, Ferguson AV, White MM. 2008 Obestatin inhibits vasopressin secretion: evidence for a physiological action in the control of fluid homeostasis. J Endocrinol 196:559-564
206. Samson WK, White MM, Price C, Ferguson AV. 2007 Obestatin acts in brain to inhibit thirst. Am J Physiol Regul Integr Comp Physiol 292:R637-R643
207. Green BD, Irwin N, Flatt PR. 2007 Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 28:981-987
208. Qader SS, Salehi A, Håkanson R, Lundquist I, Ekelund M. 2005 Long-term infusion of nutrients (total parenteral nutrition) suppresses circulating ghrelin in food-deprived rats. Regul Pept 131:82-88
209. Ren AJ, Guo ZF, Wang YK, Wang LG, Wang WZ, Lin L, Zheng X, Yuan WJ. 2008 Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem Biophys Res Commun 369:969-972
210. Gao XY, Kuang HY, Liu XM, Wang XY, Pan YH, Ma XX. 2008 Decreased obestatin in plasma in metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Res Clin Pract 79:e5-e6
211. Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, Nakajima K, Fujiwara Y, Hosoda H, Kangawa K, Mori M, Doki Y. 2010 Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology 138:1312-1320
212. Lippl F, Erdmann J, Lichter N, Tholl S, Wagenpfeil S, Adam O, Schusdziarra V. 2008 Relation of plasma obestatin levels to BMI, gender, age and insulin. Horm Metab Res 40:806-812
213. VolanteM, Fulcheri E, Allìa E, Cerrato M., Pucci A, Papotti M. 2002 Ghrelin expression in fetal, infant, and adult human lung. J Histochem Cytochem 50:1013-1021
214. Volante M, Allìa E, Gugliotta P, Funaro A, Broglio F, Deghenghi R, Muccioli G, Ghigo E, Papotti M. 2002 Expression of ghrelin and the GH secretagogue receptor by pancreatic islet cells and related endocrine tumours. J Clin Endocrinol Metab 87:1300-1308
215. Gualillo O, Caminos J, Blanco M, Garcìa-Caballero T, Kojima M, Kangawa K, Dieguez C, Casanueva F. 2001 Ghrelin, a novel placental-derived hormone. Endocrinology 142:788-794
216. Iglesias MJ, Piñeiro R, Blanco M, Gallego R, Diéguez C, Gualillo O, González-Juanatey JR, Lago F. 2004 Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 62:481-488
217. Gaytan F, Barreiro ML, Chopin LK, Herington AC, Morales C, Pinilla L, Casanueva FF, Aguilar E, Diéguez C, Tena-Sempere M. 2003 Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary. J Clin Endocrinol Metab 88:879-887
218. Ueberberg B, Unger N, Saeger W, Mann K, Petersenn S. 2009 Expression of ghrelin and its receptor in human tissues. Horm Metab Res 41:814-821
219. Gaytan F, Barreiro ML, Caminos JE, Chopin LK, Herington AC, Morales C, Pinilla L, Paniagua R, Nistal M, Casanueva FF, Aguilar E, Diéguez C, Tena-Sempere M. 2004 Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab 89:400-409
220. Wasko R, Jaskuła M, Plewa R, Komarowska H, Poreba E, GoŸdzicka-Józefiak A, Liebert W, Bednarek J, Sowiñski J. 2006 The evaluation of ghrelin mRNA expression in human somatotroph adenomas. Neuro Endocrinol Lett 27: 169-173
221. Wasko R, Jaskula M, Kotwicka M, Andrusiewicz M, Jankowska A, Liebert W, Sowinski J. 2008 The expression of ghrelin in somatotroph and other types of pituitary adenomas. Neuro Endocrinol Lett 29:929-938
222. Ueberberg B, Unger N, Sheu SY, Walz MK, Schmid KW, Saeger W, Mann K, Petersenn S. 2008 Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal gland. Horm Metab Res 40:181-188
223. Raghay K, García-Caballero T, Nogueiras R, Morel G, Beiras A, Diéguez C, Gallego R. 2006 Ghrelin localization in rat and human thyroid and parathyroid glands and tumours. Histochem Cell Biol 125:239-246
224. Leontiou CA, Franchi G, Korbonits M. 2007 Ghrelin in neuroendocrine organs and tumours. Pituitary 10:213-225
225. Kim K, Sanno N, Arai K, Takano K, Yasufuku-Takano J, Teramoto A, Shibasaki T. 2003 Ghrelin mRNA and GH secretagogue receptormRNAin human GH-producing pituitary adenomas is affected by mutations in the _ subunit of G protein. Clin Endocrinol (Oxf) 59:630-636
226. Wang W, Zhang D, Zhao H, Chen Y, Liu Y, Cao C, Han L, Liu G. 2010 Ghrelin inhibits cell apoptosis induced by lipotoxicity in pancreatic_-cell line. Regul Pept 161:43-50
227. Aydin S, Ozercan IH, Dagli F, Aydin S, Dogru O, Celebi S, Akin O, Guzel SP. 2005 Ghrelin immunohistochemistry of gastric adenocarcinoma and mucoepidermoid carcinoma of salivary gland. Biotech Histochem 80:163-168
228. An JY, Choi MG, Noh JH, Sohn TS, Jin DK, Kim S. 2007 Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer. J Surg Res 143:344-349
229. Ekeblad S, Nilsson B, Lejonklou MH, Johansson T, Stålberg P, Nilsson O, Ahlman H, Skogseid B. 2006 Gastrointestinal stromal tumors express the orexigen ghrelin. Endocr Relat Cancer 13:963-970
230. Ekeblad S, Lejonklou MH, Grimfjärd P, Johansson T, Eriksson B, Grimelius L, Stridsberg M, Stålberg P, Skogseid B. 2007 Co-expression of ghrelin and its receptor in pancreatic endocrine tumours. Clin Endocrinol (Oxf) 66:115-122
231. Dagli AF, Aydin S, Karaoglu A, Akpolat N, Ozercan IH, Ozercan MR. 2009 Ghrelin expression in normal kidney tissue and renal carcinomas. Pathol Res Pract 205:165-173
232. Dagli AF, Aydin S, Kocdor H, Gurates B, Sahin I, Catak Z, Ozercan MR, Ozercan IH. 2011 Ghrelin expression of endometrium hyperplasia and endometrioid carcinoma. Gynecol Endocrinol 27:199-204
233. Rotondo F, Cusimano M, Scheithauer BW, Rotondo A, Syro LV, Kovacs K. 2011 Ghrelin immunoexpression in pituitary adenomas. Pituitary 14:318-322
234. Kanamoto N, Akamizu T, Hosoda H, Hataya Y, Ariyasu H, Takaya K, Hosoda K, Saijo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K, Nakao K. 2001 Substantial production of ghrelin by a human medullary thyroid carcinoma cell line. J Clin Endocrinol Metab 86:4984-4990
235. Dixit VD, Weeraratna AT, Yang H, Bertak D, Cooper-Jenkins A, Riggins GJ, Eberhart CG, Taub DD. 2006 Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility. J Biol Chem 281:16681-16690
236. Pazos Y, Alvarez CJ, Camiña JP, Casanueva FF. 2007 Lysophosphatidic acid inhibits ghrelin secretion in the human gastric adenocarcinoma AGS cell line: role of mitogenic activated protein kinase signaling pathway. FEBS J 274: 5714-5726
237. La Rosa S, Boni L, Finzi G, Vigetti D, Papanikolaou N, Tenconi SM, Dionigi G, Clerici M, Garancini S, Capella C. 2010 Ghrelin-producing well-differentiated neuroendocrine tumor (carcinoid) of tailgut cyst. Morphological, immunohistochemical, ultrastructural, and RT-PCR study of a case and review of the literature. Endocr Pathol 21:190-198
238. Arnaldi G, Mancini T, Kola B, Appolloni G, Freddi S, Concettoni C, Bearzi I, Masini A, Boscaro M, Mantero F. 2003 Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. J Clin Endocrinol Metab 88:5834-5840
239. Latta E, Rotondo F, Leiter LA, Horvath E, Kovacs K. 2012 Ghrelin- and serotonin-producing gastric carcinoid. J Gastrointest Cancer 43:319-323
240. Corbetta S, Peracchi M, Cappiello V, Lania A, Lauri E, Vago L, Beck-Peccoz P, Spada A. 2003 Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J Clin Endocrinol Metab 88:3117-3120
241. Papotti M, Cassoni P, Volante M, Deghenghi R, Muccioli G, Ghigo E. 2001 Ghrelin-producing endocrine tumors of the stomach and intestine. J Clin Endocrinol Metab 86: 5052-5059
242. Grönberg M, Fjällskog ML, Jirström K, Janson ET. 2012 Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer. Acta Oncol 51:386-393
243. D'Onghia V, Leoncini R, Carli R, Santoro A, Giglioni S, Sorbellini F, Marzocca G, Bernini A, Campagna S, Marinello E, Vannoni D. 2007 Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI. Biomed Pharmacother 61:137-141
244. Lim CT, Kola B, Grossman A, Korbonits M. 2011 The expression of ghrelin O-acyltransferase (GOAT) in human tissues. Endocr J 58:707-710
245. Mercer TR, Dinger ME, Mattick JS. 2009 Long non-coding RNAs: insights into functions. Nat Rev Genet 10:155-159
246. Jeffery PL, Herington AC, Chopin LK. 2003 The potential autocrine/paracrine roles of ghrelin and its receptor in hormone dependent cancer. Cytokine Growth Factor Rev 14: 113-122
247. Gaytan F, Morales C, Barreiro ML, Jeffery P, Chopin LK, Herington AC, Casanueva FF, Aguilar E, Dieguez C, Tena-Sempere M. 2005 Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, Mullerian duct derivatives, and ovarian tumors. J Clin Endocrinol Metab 90: 1798-1804
248. Adams EF, Huang B, BuchfelderM, Howard A, Smith RG, Feighner SD, van der Ploeg LH, Bowers CY, Fahlbusch R. 1998 Presence of growth hormone secretagogue receptor messenger ribonucleic acid in human pituitary tumors and rat GH3 cells. J Clin Endocrinol Metab 83:638-642
249. Barreiro ML, Pineda R, Gaytan F, Archanco M, Burrell MA, Castellano JM, Hakovirta H, Nurmio M, Pinilla L, Aguilar E, Toppari J, Dieguez C, Tena-Sempere M. 2005 Pattern of orexin expression and direct biological actions of orexin-a in rat testis. Endocrinology 146:5164-5175
250. Skinner MM, Nass R, Lopes B, Laws ER, Thorner MO. 1998 Growth hormone secretagogue receptor expression in human pituitary tumors. J Clin Endocrinol Metab 83: 4314-4320
251. Xu T, Ye F, Wang B, Tian C, Wang S, Shu K, Guo D, Lei T. 2010 Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormonesecreting pituitary adenoma harboringGprotein_ subunit mutation. Neuro Endocrinol Lett 31:147-154
252. Barzon L, Pacenti M, Masi G, Stefani AL, Fincati K, Palu' G. 2005 Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Oncology 68:414-421
253. Ghe' C, Cassoni P, Catapano F, Marrocco T, Deghenghi R, Ghigo E, Muccioli G, Papotti M. 2002 The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology 143:484-491
254. Takahashi K, Furukawa C, Takano A, Ishikawa N, Kato T, Hayama S, Suzuki C, Yasui W, Inai K, Sone S, Ito T, Nishimura H, Tsuchiya E, Nakamura Y, Daigo Y. 2006 The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor1oncogenic signaling pathway as a therapeutic target for lung cancer. Cancer Res 66: 9408-9419
255. Papotti M, Ghe' C, Cassoni P, Catapano F, Deghenghi R, Ghigo E, Muccioli G. 2000 Growth hormone secretagogue binding sites in peripheralhumantissues. J Clin Endocrinol Metab 85:3803-3807
256. Lu C, McFarland MS, Nesbitt RL, Williams AK, Chan S, Gomez-Lemus J, Autran-Gomez AM, Al-Zahrani A, Chin JL, Izawa JI, Luyt LG, Lewis JD. 2012 Ghrelin receptor as a novel imaging target for prostatic neoplasms. Prostate 72:825-833
257. Potter R, Horti AG, Ravert HT, Holt DP, Finley P, Scheffel U, Dannals RF, Wahl RL. 2011 Synthesis and in vivo evaluation of (S)-6-(4-fluorophenoxy)-3-((1-[11C]methylpiperidin-3-yl)methyl)-2-o-tolylquinazol in-4(3H)-one, a potential PET tracer for growth hormone secretagogue receptor (GHSR). Bioorg Med Chem 19:2368-2372
258. Chollet C, Bergmann R, Pietzsch J, Beck-Sickinger AG. 2012 Design, evaluation and comparison of ghrelin receptor agonists and inverse agonists as suitable radiotracers for PET imaging. Bioconjug Chem 23:771-784
259. Liu B, Garcia EA, Korbonits M. 2011 Genetic studies on the ghrelin, growth hormone secretagogue receptor (GHSR) and ghrelin O-acyl transferase (GOAT) genes. Peptides 32: 2191-2207
260. Wagner K, Hemminki K, Grzybowska E, Klaes R, Burwinkel B, Bugert P, Schmutzler RK, Wappenschmidt B, Butkiewicz D, Pamula J, Pekala W, Försti A. 2006 Polymorphisms in genes involved in GH1 release and their association with breast cancer risk. Carcinogenesis 27:1867-1875
261. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S, Ferreira T, Wood AR, Weyant RJ, Segre' AV, Speliotes EK, Wheeler E, Soranzo N, Park JH, Yang J, Gudbjartsson D, Heard-Costa NL, Randall JC, Qi L, Vernon Smith A, Mägi R, Pastinen T, Liang L, Heid IM, Luan J, Thorleifsson G, Winkler TW, Goddard ME, Sin Lo K, Palmer C, et al. 2010 Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467:832-838
262. Gueorguiev M, Lecoeur C, Meyre D, Benzinou M, Mein CA, Hinney A, Vatin V, Weill J, Heude B, Hebebrand J, Grossman AB, Korbonits M, Froguel P. 2009 Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesity. Obesity 17:745-754
263. Feigelson HS, Teras LR, Diver WR, Tang W, Patel AV, Stevens VL, Calle EE, Thun MJ, Bouzyk M. 2008 Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II. Breast Cancer Res 10:R57
264. Doecke JD, Zhao ZZ, Stark MS, Green AC, Hayward NK, Montgomery GW, Webb PM, Whiteman DC. 2008 Single nucleotide polymorphisms in obesity-related genes and the risk of esophageal cancers. Cancer Epidemiol Biomarkers Prev 17:1007-1012
265. Wu IC, Zhao Y, Zhai R, Liu G, Ter-Minassian M, Asomaning K, Su L, Liu CY, Chen F, Kulke MH, Heist RS, Christiani DC. 2011 Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma. Neoplasia 13:386-392
266. Steinle NI, Pollin TI, O'Connell JR, Mitchell BD, Shuldiner AR. 2005 Variants in the ghrelin gene are associated with metabolic syndrome in the Old Order Amish. J Clin Endocrinol Metab 90:6672-6677
267. Skibola CF, Holly EA, Forrest MS, Hubbard A, Bracci PM, Skibola DR, Hegedus C, Smith MT. 2004 Body mass index, leptin and leptin receptor polymorphisms, and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 13: 779-786
268. Hindorff LA, MacArthur J, Wise A, Junkins HA, Hall PN, KlemmAK, Manolio TA. 2012Acatalog of published genomewide association studies. www.genome.gov/gwastudies. Accessed 12/3/11
269. Kang JU, Koo SH, Kwon KC, Park JW, Kim JM. 2009 Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung. BMC Cancer 9:237
270. Sattler HP, Lensch R, Rohde V, Zimmer E, Meese E, Bonkhoff H, Retz M, Zwergel T, Bex A, Stoeckle M, Wullich B. 2000 Novel amplification unit at chromosome 3q25-q27 in human prostate cancer. Prostate 45:207-215
271. Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL. 2006 Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 7:127
272. Barbieri CE, Demichelis F, Rubin MA. 2012 Molecular genetics of prostate cancer: emerging appreciation of genetic complexity. Histopathology 60:187-198
273. Rodríguez-Paredes M, Esteller M. 2011 Cancer epigenetics reaches mainstream oncology. Nat Med 17:330-339
274. Ordway JM, Budiman MA, Korshunova Y, Maloney RK, Bedell JA, Citek RW, Bacher B, Peterson S, Rohlfing T, Hall J, Brown R, Lakey N, Doerge RW, Martienssen RA, Leon J, McPherson JD, Jeddeloh JA. 2007 Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS One 2:e1314
275. Inoue H, Sakamoto Y, Kangawa N, Kimura C, Ogata T, Fujieda K, Qian ZR, Sano T, Itakura M. 2011 Analysis of expression and structure of the rat GH-secretagogue/ghrelin receptor (Ghsr) gene: roles of epigenetic modifications in transcriptional regulation. Mol Cell Endocrinol 345: 1-15
276. Rius M, Lyko F. 19 December 2011 Epigenetic cancer therapy: rationales, targets and drugs. Oncogene doi: 10.1038/ onc.2011.601
277. Malendowicz W, Ziolkowska A, Szyszka M, Kwias Z. 2009 Elevated blood active ghrelin and unaltered total ghrelin and obestatin concentrations in prostate carcinoma. Urol Int 83:471-475
278. Markowska A, Ziolkowska A, Nowinka K, Malendowicz LK. 2009 Elevated blood active ghrelin and normal total ghrelin and obestatin concentrations in uterine leiomyoma. Eur J Gynaecol Oncol 30:281-284
279. Nakazato M., Murakami N, Date Y, Kojima M., Matsuo H, Kangawa K, Matsukura S. 2001 A role for ghrelin in the central regulation of feeding. Nature 409:194-198
280. Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, Epstein N, Oberman B, Catane R, Kaufman B, Shimon I. 2006 Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 106:966-973
281. Karapanagiotou EM, Polyzos A, Dilana KD, Gratsias I, Boura P, Gkiozos I, Syrigos KN. 2009 Increased serum levels of ghrelin at diagnosis mediate body weight loss in nonsmall cell lung cancer (NSCLC) patients. Lung Cancer 66: 393-398
282. Huang Q, Fan YZ, Ge BJ, Zhu Q, Tu ZY. 2007 Circulating ghrelin in patients with gastric or colorectal cancer. Dig Dis Sci 52:803-809
283. Prudom C., Liu J, Patrie J, Gaylinn B D., Foster-Schubert KE, Cummings DE, Thorner MO, Geysen HM. 2010 Comparison of competitive radioimmunoassays and two-site sandwich assays for the measurement and interpretation of plasma ghrelin levels. J Clin Endocrinol Metab 95:2351-2358
284. Hotta M., Ohwada R., Katakami H, Shibasaki T, Hizuka N, Takano K. 2004 Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J Clin Endocrinol Metab 89:5707-5712
285. Gröschl M, Uhr M, Kraus T. 2004 Evaluation of the comparability of commercial ghrelin assays. Clin Chem 50: 457-458
286. Stengel A, Keire D, Goebel M, Evilevitch L, Wiggins B, Taché Y, Reeve Jr JR. 2009 The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology 150:5113-5118
287. Blatnik M, Soderstrom CI. 2011 A practical guide for the stabilization of acylghrelin in human blood collections. Clin Endocrinol (Oxf) 74:325-331
288. Hosoda H, Doi K, Nagaya N, Okumura H, Nakagawa E, Enomoto M, Ono F, Kangawa K. 2004Optimumcollection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clin Chem 50:1077-1080
289. Markowska A, Ziółkowska A, Jaszczyñska-Nowinka K, Madry R, Malendowicz LK. 2009 Elevated blood plasma concentrations of active ghrelin and obestatin in benign ovarian neoplasms and ovarian cancers. Eur J Gynaecol Oncol 30:518-522
290. Tham E, Liu J, Innis S, Thompson D, Gaylinn BD, Bogarin R, Haim A, Thorner MO, Chanoine JP. 2009 Acylated ghrelin concentrations are markedly decreased during pregnancy in mothers with and without gestational diabetes: relationship with cholinesterase. Am J Physiol Endocrinol Metab 296:E1093-E1100
291. Mungan NA, Eminferzane S, Mungan AG, Yesilli C, Seckiner I, Can M, Ayoglu F, Akduman B. 2008 Diagnostic value of serum ghrelin levels in prostate cancer. Urol Int 80:245-248
292. Kosowicz J, Baumann-Antczak A, Zamysłowska H, Sowiñski J. 2011 Technological difficulties in ghrelin and obestatin assays. Endokrynologia Polska 62:336-339
293. Rauh M, Gröschl M, Rascher W. 2007 Simultaneous quantification of ghrelin and desacyl-ghrelin by liquid chromatography-tandem mass spectrometry in plasma, serum, and cell supernatants. Clin Chem 53:902-910
294. Akamizu T, Shinomiya T, Irako T, Fukunaga M, Nakai Y, Nakai Y, Kangawa K. 2005 Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab 90:6-9
295. Trivedi A, Babic S, Chanoine JP. 2012 Pitfalls in the determination ofhumanacylated ghrelin plasma concentrations using a double antibody enzyme immunometric assay. Clin Biochem 45:178-180
296. Bertaccini A, Pernetti R, Marchiori D, Pagotto U, Palladoro F, Palmieri F, Vitullo G, Guidi M, Martorana G. 2009 Variations in blood ghrelin levels in prostate cancer patients submitted to hormone suppressive treatment. Anticancer Res 29:1345-1348
297. Morpurgo PS, Cappiello V, Verga U, Vicentini L, Vaghi I, Lauri E, Nebuloni M, Beck-Peccoz P, Spada A. 2005 Ghrelin in human medullary thyroid carcinomas. Clin Endocrinol (Oxf) 63:437-441
298. Zub-Pokrowiecka A, Rembiasz K, Konturek PC, Budzyñski A, Konturek SJ, Winiarski M, Bielañski W. 2011 Ghrelin and gastrin in advanced gastric cancer before and after gastrectomy. World J Gastroenterol 17:449-458
299. Jeon TY, Lee S, Kim HH, Kim YJ, Son HC, Kim DH, Sim MS. 2004 Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab 89:5392-5396
300. Zub-Pokrowiecka A, Rembiasz K, Konturek SJ, Budzynski A, Konturek PC, Budzynski P. 2010 Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection. Med Sci Monit 16:CR493-CR500
301. Takiguchi S, Adachi S, Yamamoto K, Morii E, Miyata H, Nakajima K, Yamasaki M, Kangawa K, Mori M, Doki Y. 2012 Mapping analysis of ghrelin producing cells in the human stomach associated with chronic gastritis and early cancers. Dig Dis Sci 57:1238-1246
302. Murphy G, Kamangar F, Dawsey SM, Stanczyk FZ, Weinstein SJ, Taylor PR, Virtamo J, Abnet CC, Albanes D, Freedman ND. 2011 The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas. J Natl Cancer Inst 103:1123-1129
303. Tsolakis AV, Portela-GomesGM, Stridsberg M., Grimelius L, Sundin A, Eriksson BK, Oberg KE, Janson ET. 2004 Malignant gastric ghrelinoma with hyperghrelinemia. J Clin Endocrinol Metab 89:3739-3744
304. Walter T, Chardon L, Hervieu V, Cohen R, Chayvialle JA, Scoazec JY, Lombard-Bohas C. 2009 Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases. Eur J Endocrinol 161:639-645
305. Iwakura H, Ariyasu H, Li Y, Kanamoto N, Bando M, Yamada G, Hosoda H, Hosoda K, Shimatsu A, Nakao K, Kangawa K, Akamizu T. 2009 A mouse model of ghrelinoma exhibited activated growth hormone-insulin-like growth factor I axis and glucose intolerance. Am J Physiol Endocrinol Metab 297:E802-E811
306. Gallagher EJ, LeRoith D. 2010 The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab 21:610-618
307. Takahashi M, Terashima M, Takagane A, Oyama K, Fujiwara H, Wakabayashi G. 2009 Ghrelin and leptin levels in cachectic patients with cancer of the digestive organs. Int J Clin Oncol 14:315-320
308. Broglio F, Gianotti L, Destefanis S, Fassino S, Abbate Daga G, Mondelli V, Lanfranco F, Gottero C, Gauna C, Hofland L, Van der Lely AJ, Ghigo E. 2004 The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol (Oxf) 60:592-599
309. Crown AL, Cottle K, Lightman SL, Falk S, Mohamed-Ali V, Armstrong L, Millar AB, Holly JM. 2002 What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated? Clin Endocrinol (Oxf) 56:723-733
310. Garcia JM, Garcia-Touza M, Hijazi RA, Taffet G, Epner D, MannD, Smith RG, Cunningham GR, Marcelli M. 2005 Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 90: 2920-2926
311. Baatar D, Patel K, Taub DD. 2011 The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol 340:44-58
312. Rubin H. 2003 Cancer cachexia: its correlations and causes. Proc Natl Acad Sci USA 100:5384-5389
313. Kemik O, Sumer A, Kemik AS, Hasirci I, Purisa S, Dulger AC, Demiriz B, Tuzun S. 2010 The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J Surg Oncol 8:85
314. Legakis I, Stathopoulos J, Matzouridis T, Stathopoulos GP. 2009 Decreased plasma ghrelin levels in patients with advanced cancer and weight loss in comparison to healthy individuals. Anticancer Res 29:3949-3952
315. Kerem M, Ferahkose Z, Yilmaz UT, Pasaoglu H, Ofluoglu E, Bedirli A, Salman B, Sahin TT, Akin M. 2008 Adipokines and ghrelin in gastric cancer cachexia. World J Gastroenterol 14:3633-3641
316. Hanahan D, Weinberg RA. 2000 The hallmarks of cancer. Cell 100:57-70
317. Hanahan D, Weinberg RA. 2011 Hallmarks of cancer: the next generation. Cell 144:646-674
318. Rossi F, Castelli A, Bianco MJ, Bertone C, Brama M, Santiemma V. 2009 Ghrelin inhibits contraction and proliferation of human aortic smooth muscle cells by cAMP/PKA pathway activation. Atherosclerosis 203:97-104
319. Park YJ, Lee YJ, Kim SH, Joung DS, Kim BJ, So I, Park do J, Cho BY. 2008 Ghrelin enhances the proliferating effect of thyroid stimulating hormone in FRTL-5 thyroid cells. Mol Cell Endocrinol 285:19-25
320. Tian C, Ye F, Wang L, Deng Y, Dong Y, Wang X, Xu T, Lei T, Wang X. 2010 Nitric oxide inhibits ghrelin-induced cell proliferation and ERK1/2 activation in GH3 cells. Endocrine 38:412-416
321. Gonzalez-Rey E, Chorny A, Delgado M. 2006 Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 130:1707-1720
322. Lee HJ, Kang YM, Moon CS, Joe MK, Lim JH, Suh YH, Song J, Jung MH. 2009 KLF4 positively regulates human ghrelin expression. Biochem J 420:403-411
323. Król M, Polañska J, Pawłowski KM, Turowski P, Skierski J, Majewska A, Ugorski M, Morty RE, Motyl T. 2010 Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungs. J Appl Genet 51:37-50
324. Yang J, Zhao TJ, Goldstein JL, Brown MS. 2008 Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides. Proc Natl Acad Sci USA 105:10750-10755
325. Wang W, Andersson M, Iresjö BM, Lönnroth C, Lundholm K. 2006 Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia. Int J Oncol 28: 1393-1400
326. DeBoer MD, Zhu XX, Levasseur P, Meguid MM, Suzuki S, Inui A, Taylor JE, Halem HA, Dong JZ, Datta R, Culler MD, Marks DL. 2007 Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 148:3004-3012
327. Wei W, Qi X, Reed J, Ceci J, Wang HQ, Wang G, Englander EW, Greeley Jr GH. 2006 Effect of chronic hyperghrelinemia on ingestive action of ghrelin. Am J Physiol Regul Integr Comp Physiol 290:R803-R808
328. Belloni AS, Macchi C, Rebuffat P, Conconi MT, Malendowicz LK, Parnigotto PP, Nussdorfer GG. 2004 Effect of ghrelin on the apoptotic deletion rate of different types of cells cultured in vitro. Int J Mol Med 14:165-167
329. Konturek PC, Burnat G, Rau T, Hahn EG, Konturek S. 2008 Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci 53:597-605
330. Brzozowski T, Konturek PC, Konturek SJ, Kwiecieñ S, Drozdowicz D, Bielanski W., Pajdo R, Ptak A, Nikiforuk A, Pawlik WW, Hahn EG. 2004 Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul Pept 120:39-51
331. Chang L, Ren Y, Liu X, LiWG, Yang J, Geng B, Weintraub NL, TangC. 2004 Protective effects of ghrelin on ischemia/ reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol 43:165-170
332. Konturek PC, Brzozowski T, Engel M, Burnat G, Gaca P, Kwiecien S, Pajdo R, Konturek SJ. 2009 Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. J Physiol Pharmacol 60:41-47
333. Lee JY, Chung H, Yoo YS, Oh YJ, Oh TH, Park S, Yune TY. 2010 Inhibition of apoptotic cell death by ghrelin improves functional recovery after spinal cord injury. Endocrinology 151:3815-3826
334. Zhang GG, Teng X, Liu Y, Cai Y, Zhou YB, Duan XH, Song JQ, Shi Y, Tang CS, Yin XH, Qi YF. 2009 Inhibition of endoplasm reticulum stress by ghrelin protects against ischemia/reperfusion injury in rat heart. Peptides 30: 1109-1116
335. Lau PN, Chow KB, Chan CB, Cheng CH, Wise H. 2009 The constitutive activity of the ghrelin receptor attenuates apoptosis via a protein kinase C-dependent pathway. Mol Cell Endocrinol 299:232-239
336. Holst B, Holliday ND, Bach A, Elling CE, Cox HM, Schwartz TW. 2004 Common structural basis for constitutive activity of the ghrelin receptor family. J Biol Chem 279:53806-53817
337. Rossi F, Bertone C, Petricca S, Santiemma V. 2007 Ghrelin inhibits angiotensin II-induced migration of human aortic endothelial cells. Atherosclerosis 192:291-297
338. Conconi MT, Nico B, Guidolin D, Baiguera S, Spinazzi R, Rebuffat P, Malendowicz LK, Vacca A, Carraro G, Parnigotto PP, Nussdorfer GG, Ribatti D. 2004 Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo. Peptides 25:2179-2185
339. Li A, Cheng G, Zhu GH, Tarnawski AS. 2007 Ghrelin stimulates angiogenesis in human microvascular endothelial cells: implications beyond GH release. Biochem Biophys Res Commun 353:238-243
340. Ahluwalia A, Li A, Cheng G, Deng X, Tarnawski AS. 2009 Reduced ghrelin in endothelial cells plays important mechanistic role in aging-related impairment of angiogenesis. J Physiol Pharmacol 60:29-34
341. Yang C, Wang Y, Liu H, Li N, Sun Y, Liu Z, Yang P. 2012 Ghrelin protects H9c2 cardiomyocytes from angiotensin II-induced apoptosis through the endoplasmic reticulum stress pathway. J Cardiovasc Pharmacol 59:465-471
342. Haabeth OA, Lorvik KB, Hammarström C, Donaldson IM, Haraldsen G, Bogen B, Corthay A. 2011 Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat Commun 2:240
343. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. 2009 Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081
344. Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E, Krieg A, Weiner GJ, Fox BA, Coukos G, Wang E, Abraham RT, Carbone M, Lotze MT. 2010 Cancer and inflammation: promise for biologic therapy. J Immunother 33: 335-351
345. de Martel C, Haggerty TD, Corley DA, Vogelman JH, Orentreich N, Parsonnet J. 2007 Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. Am J Gastroenterol 102:1166-1172
346. Hou Y, An J, Hu XR, Sun BB, Lin J, Xu D, Wang T, Wen FQ. 2009 Ghrelin inhibits interleukin-8 production induced by hydrogen peroxide in A549 cells via NF-_B pathway. Int Immunopharmacol 9:120-126
347. Azad N, Rojanasakul Y, Vallyathan V. 2008 Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 11:1-15
348. Osawa H. 2008 Ghrelin and Helicobacter pylori infection. World J Gastroenterol 14:6327-6333
349. Deboer MD. 2011 Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerations. Int J Pept 2011:189242
350. Ghosh N, Chaki R, Mandal V, Mandal SC. 2010 COX-2 as a target for cancer chemotherapy. Pharmacol Rep 62:233-244
351. Zhao D, Zhan Y, Zeng H, Moyer MP, Mantzoros CS, Pothoulakis C. 2006 Ghrelin stimulates interleukin-8 gene expression through protein kinase C-mediated NF-_B pathway in human colonic epithelial cells. J Cell Biochem 97:1317-1327
352. De Smet B, Thijs T, Moechars D, Colsoul B, Polders L, Ver Donck L, Coulie B, Peeters TL, Depoortere I. 2009 Endogenous and exogenous ghrelin enhance the colonic and gastric manifestations of dextran sodium sulphate-induced colitis in mice. Neurogastroenterol Motil 21:59-70
353. Ataseven H, Bahcecioglu IH, Kuzu N, Yalniz M, Celebi S, Erensoy A, Ustundag B. 2006 The levels of ghrelin, leptin, TNF-_, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm 2006:78380
354. DeBoer MD. 2011 Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes? Mol Cell Endocrinol 340:97-105
355. Loberg RD, Bradley DA, Tomlins SA, Chinnaiyan AM, Pienta KJ. 2007 The lethal phenotype of cancer: the molecular basis of death due to malignancy. CA Cancer J Clin 57:225-241
356. Lundholm K, Gunnebo L, Körner U, Iresjö BM, Engström C, Hyltander A, Smedh U, Bosaeus I. 2010 Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study. Cancer 116:2044-2052
357. Hanada T, Toshinai K, Kajimura N, Nara-Ashizawa N, Tsukada T, Hayashi Y, Osuye K, Kangawa K, Matsukura S, Nakazato M. 2003 Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochem Biophys Res Commun 301:275-279
358. Hanada T, Toshinai K, Date Y, Kajimura N, Tsukada T, Hayashi Y, Kangawa K, Nakazato M. 2004 Upregulation of ghrelin expression in cachectic nude mice bearing human melanoma cells. Metabolism 53:84-88
359. Chance W.T., Dayal R, Friend LA, Thomas I, Sheriff S. 2008 Continuous intravenous infusion of ghrelin does not stimulate feeding in tumor-bearing rats. Nutr Cancer 60:75-90
360. Neary N.M., Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, Frost GS, Ghatei MA, Coombes RC, Bloom SR. 2004 Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89:2832-2836
361. Garcia JM, Polvino WJ. 2007 Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers. Oncologist 12:594-600
362. Liu YL, Malik NM, Sanger GJ, Andrews PL. 2006 Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents. Cancer Chemother Pharmacol 58:326-333
363. Yakabi K, Sadakane C, Noguchi M, Ohno S, Ro S, Chinen K, Aoyama T, Sakurada T, Takabayashi H, Hattori T. 2010 Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology 151:3773-3782
364. Rudd JA, Ngan MP, Wai MK, King AG, Witherington J, Andrews PL, Sanger GJ. 2006 Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin. Neurosci Lett 392:79-83
365. Wang L, Chen Q, Li G, Ke D. 2012 Ghrelin stimulates angiogenesis via GHSR1a-dependent MEK/ERK and PI3K/Akt signal pathways in rat cardiac microvascular endothelial cells. Peptides 33:92-100
366. Strasser F, Lutz TA, Maeder M T., Thuerlimann B, Bueche D, Tschöp M, Kaufmann K, Holst B, Brändle M, von Moos R, Demmer R, Cerny T. 2008 Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/ cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer 98:300-308
367. Gao XY, Kuang HY, Liu XM, Ma ZB, Nie HJ, Guo H. 2008 Plasma obestatin levels in men with chronic atrophic gastritis. Peptides 29:1749-1754
368. Dun SL, Brailoiu GC, Brailoiu E, Yang J, Chang JK, Dun NJ. 2006 Distribution and biological activity of obestatin in the rat. J Endocrinol 191:481-489
369. Grönberg M, Tsolakis AV, Magnusson L, Janson ET, Saras J. 2008 Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem 56:793-801
370. Karaoglu A, Aydin S, Dagli AF, Cummings DE, Ozercan IH, Canatan H, Ozkan Y. 2009 Expression of obestatin and ghrelin in papillary thyroid carcinoma. Mol Cell Biochem 323:113-118
371. Alnema MM, Aydin S, Ozkan Y, Dagli AF, Ozercan HI, Yildirim N, Sahin I, Karaoglu A, Kilic N, Yilmaz M, Ozercan MR, Donder E. 2010 Ghrelin and obestatin expression in oral squamous cell carcinoma: an immunohistochemical and biochemical study. Mol Cell Biochem 339:173-179
372. Gao XY, Kuang HY, Liu XM, Duan P, Yang Y, Ma ZB. 2009 Circulating ghrelin/obestatin ratio in subjects with Helicobacter pylori infection. Nutrition 25:506-511
373. Alvarez CJ, Lodeiro M, Theodoropoulou M, Camiña JP, Casanueva FF, Pazos Y. 2009 Obestatin stimulates Akt signalling in gastric cancer cells through _-arrestin-mediated epidermal growth factor receptor transactivation. Endocr Relat Cancer 16:599-611
374. Xie F, Liu H, Zhu YH, Qin YR, Dai Y, Zeng T, Chen L, Nie C, Tang H, Li Y, Fu L, Guan XY. 2011 Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma. BMC Cancer 11:86
375. Alloatti G, Arnoletti E, Bassino E, Penna C, Perrelli MG, Ghé C, Muccioli G. 2010 Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes. Am J Physiol Heart Circ Physiol 299:H470-H81
376. Mészárosová M, Sirotkin AV, Grossmann R, Darlak K, Valenzuela. 2008 The effect of obestatin on porcine ovarian granulosa cells. Anim Reprod Sci 108:196-207
377. Ceranowicz P, Warzecha Z, Dembinski A, Cieszkowski J, Dembinski M, Sendur R, Kusnierz-Cabala B, Tomaszewska R, Kuwahara A, Kato I. 2009 Pretreatment with obestatin inhibits the development of cerulein-induced pancreatitis. J Physiol Pharmacol 60:95-101
378. Stevanoviæ D, Miloseviæ V, Starceviæ VP, Severs WB. 2007 The effect of centrally administered ghrelin on pituitary ACTH cells and circulating ACTH and corticosterone in rats. Life Sci 80:867-872
379. Baiguera S, Conconi MT, Guidolin D, Mazzocchi G, Malendowicz LK, Parnigotto PP, Spinazzi R, Nussdorfer GG. 2004 Ghrelin inhibits in vitro angiogenic activity of rat brain microvascular endothelial cells. Int J Mol Med 14: 849-854
380. Chopin LK, Herington AC. 2001 A potential autocrine/ paracrine pathway for GHRH and its receptor in human prostate cancer cell lines. Prostate 49:116-121
381. Smith K. 2012Prostate cancer:GHRHantagonists could be effective in CRPC treatment. Nat Rev Urol 9:120
382. Letsch M, Schally AV, Szepeshazi K, Halmos G, Nagy A. 2004 Effective treatment of experimental androgen sensitive and androgen independent intraosseous prostate cancer with targeted cytotoxic somatostatin analogue AN- J Urol 171:911-915
383. Plonowski A, Schally AV, Letsch M, Krupa M, Hebert F, Busto R, Groot K, Varga JL. 2002 Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor. Prostate 52: 173-182
384. Rick FG, Schally AV, Szalontay L, Block NL, Szepeshazi K, Nadji M, Zarandi M, Hohla F, Buchholz S, Seitz S. 2012 Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases. Proc Natl Acad Sci USA 109:1655-1660
385. Casanueva FF, Camiña JP, Carreira MC, Pazos Y, Varga JL, Schally AV. 2008 Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a. Proc Natl Acad Sci USA 105:20452-20457
386. Mottershead M, Karteris E, Barclay JY, Suortamo S, Newbold M, Randeva H, Nwokolo CU. 2007 Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinoma. J Clin Pathol 60:405-409
387. Wang Z, Wang W, Qiu W, Fan Y, Zhao J, Wang Y, Zheng Q. 2007 Involvement of ghrelin-growth hormone secretagogue receptor system in pathoclinical profiles of digestive system cancer. Acta Biochim Biophys Sin (Shanghai) 39: 992-998
388. Tsolakis AV, Stridsberg M, Grimelius L, Portela-Gomes GM, Falkmer SE, Waldum HL, Janson ET. 2008 Ghrelin immunoreactive cells in gastric endocrine tumors and their relation to plasma ghrelin concentration. J Clin Gastroenterol 42:381-388
389. Tsolakis AV, Grimelius L, Stridsberg M, Falkmer SE, Waldum HL, Saras J, Janson ET. 2009 Obestatin/ghrelin cells in normal mucosa and endocrine tumours of the stomach. Eur J Endocrinol 160:941-949
390. Raffel A, Krausch M, Cupisti K, Gerharz CD, Eisenberger CF, Knoefel WT. 2005 Ghrelin expression in neuroendocrine tumours of the gastrointestinal tract with multiple endocrine neoplasia type 1. Horm Metab Res 37:653-655
391. Srivastava A, Kamath A, Barry SA, Dayal Y. 2004 Ghrelin expression in hyperplastic and neoplastic proliferations of the enterochromaffin-like (ECL) cells. Endocr Pathol 15: 47-54
392. Machado MC, Sá SV, Goldbaum TS, Catania M, Campos VC, Corrêa-Giannella ML, Giannella-Neto D, Salgado LR. 2007 In vivo response to growth hormone-releasing peptide-6 in adrenocorticotropin-dependent Cushing's syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1amRNAexpression. J Endocrinol Invest 30:334-340
393. Iwakura H, Hosoda K, Doi R, Komoto I, Nishimura H, Son C, Fujikura J, Tomita T, Takaya K, Ogawa Y., Hayashi T, Inoue G, Akamizu T, Hosoda H, Kojima M, Kangawa K, Imamura M, Nakao K. 2002 Ghrelin expression in islet cell tumors: augmented expression of ghrelin in a case of glucagonoma with multiple endocrine neoplasm type I. J Clin Endocrinol Metab 87:4885-4888
394. Barlier A, Zamora AJ, Grino M, Gunz G, Pellegrini-Bouiller I, Morange-Ramos I, Figarella-Branger D, Dufour H, Jaquet P, Enjalbert A. 1999 Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in situ hybridisation and cell culture studies. J Neuroendocrinol 11:491-502
395. Nielsen S, Mellemkjaer S, Rasmussen LM, Ledet T, Astrup J, Weeke J, Jørgensen JO. 1998 Gene transcription of receptors for growth hormone-releasing peptide and somatostatin in human pituitary adenomas. J Clin Endocrinol Metab 83:2997-3000
396. Martínez-Fuentes AJ, Moreno-Fernández J, Vázquez-Martínez R, Durán-Prado M, de la Riva A, Tena-Sempere M, Diéguez C, Jiménez-Reina L, Webb SM, Pumar A, Leal-Cerro A, Benito-López P, Malagón MM, Castaño JP. 2006 Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas. J Clin Endocrinol Metab 91:2225-2231
397. Liu J, Lin H, Cheng P, Hu X, Lu H. 2009 Effects of ghrelin on the proliferation and differentiation of 3T3-L1 preadipocytes. J Huazhong Univ Sci Technolog Med Sci 29: 227-230